Study on biodistribution and radioimmunoimaging of 131iodine- labeled monoclonal antibody D-D3 against progastrin-releasing peptide (31-98) in tumor-bearing mouse

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 2, 2011, Pages 229-235

  Liu, Zengli ^a   Zhou, Xiaolin ^b   Shi, Yizhen ^a   Du, Shouying ^c   Yang, Yi ^a   Tang, Jun ^a   Shen, Yongmei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b CHINA INSTITUTE FOR RADIATION PROTECTION   (China)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

131I D D3; monoclonal antibody; proGRP (31 98); radioimmunoimaging

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D D3; MONOCLONAL ANTIBODY D D3 I 131; PROGASTRIN RELEASING PEPTIDE[31-98]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; FEMALE; HUMAN; ISOTOPE LABELING; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; MALE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOIODINATION; STOMACH CANCER; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; ISOTOPE LABELING; LUNG NEOPLASMS; MICE; MICE, NUDE; PEPTIDE FRAGMENTS; RADIOIMMUNODETECTION; RECOMBINANT PROTEINS; SMALL CELL LUNG CARCINOMA; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 79955928317     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0855     Document Type: Article

References (22)

1. McDonald TJ, Nilsson G, Vagne M, et al. A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut 1978;19:767.
2. McDonald TJ, Jö rnvall H, Nilsson G, et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979;90:227.
3. Bunnett N. Gastrin releasing peptide. In: Walsh JH, Dockray GJ (eds.), Gut Peptides. New York: Raven Press, 1994;423-555.
4. Yamada K, Wada E, Wada K. Bombesin-like peptides: Studies on food intake and social behaviour with receptor knock-out mice. Ann Med 2000;32:519.
5. McDonald TJ, Ghatei MA, Bloom SR, et al. A qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrinreleasing peptide (GRP).Regul Pept 1981;2:293.
6. Moody TW, Russell EK, O Donohue TL, et al. Bombesin-like peptides in small cell lung cancer: Biochemical characterization and secretion from a cell line. Life Sci 1983;32:487.
7. Maruno K, Yamaguchi K, Abe K, et al. Immunoreactive gastrin releasing peptide as a specific tumor marker in patiens with small cell lung carcinoma. Cancer Res 1989;49:629.
8. Uchida K, Kojima A, Morokawa N, et al. Expression of progastrin releasing peptide and gastrin-releasing peptide receptor mRNAt ranscripts in tumor cells of patients with small cell lung Cancer. J Cancer Res Clin Oncol 2002;128:633.
9. Miyake Y, Kodama T, Yamaguchi K. Progastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54;2136.
10. Stieber P, Dienemann H, Schalhorn A, et al. Pro-gastrin-releasing peptide (ProGRP)-a useful marker in small cell lung carcinomas. Anticancer Res 1999;19(4A):2673.
11. Winther B, Moi P, Paus E, et al. Targeted determination of the early stage SCLC specific biomarker pro-gastrinreleasing peptide (ProGRP) at clinical concentration levels in human serum using LC-MS. J Sep Sci 2007;30:2638.
12. Winther B, Paus E, Reubsaet JL. Determination of the small cell lung cancer associated biomarker pro-gastrin-releasing peptide (ProGRP) using LC-MS. J Sep Sci 2007;30:234.
13. Yamaguchi H, Soda H, Kitazaki T, et al. Serum progastrinreleasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer. Respirology 2007;12:137.
14. Satoh H, Kagohashi K, Kurishima K, et al. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients. Clin Oncol (R Coll Radiol) 2006;18:720. (Pubitemid 44464047)
15. Matsubayashi H, Fujiwara S, Kobayashi Y, et al. A small cell carcinoma of the pancreas with a high level of serum ProGRP. J Clin Gastroenterol 2004;38:834.
16. Molina R, Filella X, Augé JM. ProGRP: A new biomarker for small cell lung cancer. Clin Biochem 2004;37:505.
17. Oremek GM, Sapoutzis N. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer. Anticancer Res 2003;23(2A):895.
18. Schneider J, Philipp M, Salewski L, et al. Pro-gastrinreleasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with smallcell lung cancer. Clin Lab 2003;49:35.
19. Nordlund MS, Fermer C, Nilsson O, et al. Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP. Tumour Biol 2007; 28:100.
20. Dumesny C, Patel O, Lachal S, et al. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).Endocrinology 2006;147:502.
21. O Grady LF, DeNardo G, DeNardo S. Radiolabelled monoclonal antibodies for the detection of cancer. Am J Physiol Imaging 1986;1:44.
22. Ming-fei Z, He-qiu Z, Shi-gan L. Enzyme linked immunosorbent assay of pro gastrin releasing peptide as tumor marker for small cell lung carcinoma: Research advances and clinical application. Bull Acad Mil Med Sci 2000;24:143.